Diabetes affects over 537 million people worldwide; by 2045, this is estimated to increase to 783 million. [1] With the growing prevalence of diabetes,
it's even more important to utilise all options to support people with diabetes (PwDs) in managing their daily life with diabetes.
Where do PwDs most often access healthcare support? On average, PwDs visit the pharmacy three-to-eight times more than the general population to obtain medicines
and testing supplies.[2] It is clear that pharmacists play an integral role in empowering the self-management needs of PwDs beyond the traditional role of
supplying medicines. This relationship, however, may be underutilised.
Research suggests there is a lack of broad recognition of pharmacists as a key source of diabetes care, and that resource constraints - particularly following
the COVID-19 pandemic - can interfere with patient education provision and training.[3,4] Furthermore, the circumstances and role of the pharmacy vary, nationally
and internationally. At Roche Diabetes Care we would like to shine a light on the increasing value of community pharmacists as important figures in the well-being
of PwDs.
Pharmacy teams are being encouraged to support the ground-breaking Platform Adaptive trial of Novel antivirals for early treatment of Covid-19 In the Community (PANORAMIC) study by raising awareness among patients.
The study aims to find out whether new antiviral treatments can help Covid-19 patients avoid hospital admission and support a quicker recovery.
The PANORAMIC trial will allow researchers to gather data on the potential benefits of treatments to patients and will help the NHS to develop plans for rolling out the products to further patients in 2022.
Anyone over the age of 50 or between 18 to 49 with certain underlying health conditions can participate in the trial after receiving a positive PCR or lateral flow test result for Covid-19.
People who wish to participate in the trial can sign up themselves through the study's website and may be contacted by a member of the clinical team in a general practice that has been set up to deliver the PANORAMIC trial.
The Health Education England (HEE) has secured funding to further support growth of the pharmacy technician workforce in 2022/23.
This support is through expansion of pre-registration trainee pharmacy technician (PTPT) training capacity in community pharmacy or as part of a cross-sector
integrated apprenticeship programme.
HEE will be holding two 90-minute webinars on Monday 27 2022. There will be a morning webinar (10-11.30am) and an evening webinar (7-8.30pm) for attendees to
choose from.
Topics like- available funding; eligibility for funding; PTPT training programme requirements for employers; how to apply for this funding; and the support
available from HEE for successful funding of applicants to develop their PTPT training programmes, will be covered during the webinars.
HEE is also hosting another webinar to provide an update on the Independent Prescribing (IP) for pharmacists training offer that they are developing for Autumn 2022.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for three tablets- Meptazinol (Meptid) 200mg film-coated tablets,
Medroxyprogesterone (Provera) 2.5mg tablets and Lamotrigine 5mg dispersible tablets on Wednesday (15 February).
Meptid tablets will remain out of stock until late June 2023. DHSC suggested that an alternative analgesic products including non-opioids remain available.
Provera 2.5mg tablets are out of stock until mid-March 2023. "Medroxyprogesterone (Provera) 5mg and 10mg tablets remain available but cannot support an uplift in
demand," said DHSC.
"Norethisterone 5mg tablets remain available and will be able to support an increase in demand."
Branded lamotrigine (Lamictal) 2mg and 5mg dispersible remain available but are unable to support the increase in demand as Lamotrigine 5mg dispersible tablets
are out of stock until late March 2023.
The Pharmacists Defence Association (PDA) has expressed its interest to support pharmacists impacted with the latest announcement of the closure of Tesco
pharmacies.
"Tesco have followed ASDA and LloydsPharmacy (at Sainsbury's) to announce cost cutting changes to their stores, impacting hundreds of jobs," the association said.
The PDA's interests in the announcement relate to the planned closure of eight in-store Tesco pharmacies and the impact of those closures upon pharmacists, however
the union is of course concerned for all those impacted.
The PDA Union will support individual PDA members impacted by the decision so that they are aware of, and can exercise, their rights at work in relation to this
situation.
Paul Day, PDA Union Director said, "In addition to the immediate impact on pharmacists employed at the stores marked for closure, this is the third instance in just
twelve days of reductions in the overall access to a pharmacy for NHS patients. We expect those who represent communities to be concerned about the loss of a key
part of their local NHS service."
The International Pharmaceutical Federation (FIP) has released a handbook today (February 23) on guidance for pharmacists on supporting self-care.
The handbook, "Empowering self-care: A handbook for pharmacists", covers six areas of self-care - sore throat, gastrointestinal complaints, musculoskeletal pain, fever in children, sexual health and disinfection.
Commenting on the release, Rúben Viegas, co-author of the handbook, said: Community pharmacists already help people in self-care by giving advice on non-prescription
medicines, nutrition, physical activity and lifestyle choices, but this new resource from FIP offers added support for these professional services that demonstrate our profession's commitment to primary health care."
The publication, also intended as an advocacy resource for FIP's member organisations, discusses latest trends and strategies in self-care and explores innovations adopted across several practice areas.
It aims to provide pharmacists with concise guidance on coaching practices and person-centred approaches to promote self-care.
ECG has launched a new 'simple and straightforward' Patient Group Direction (PGD) service for pharmacists working in primary care, together with a service
which offers direct access to an NHS Consultant for medical advice to offer robust safeguarding as and when needed.
Taking on more clinical services with the PGDs can feel daunting and a big responsibility for healthcare professionals. ECG's new medical advice service (for anyone
purchasing their PGDs) will offer pharmacists the opportunity to call and speak to a clinical member of the ECG team who will triage the calls and support them.
If required, the call will be connected to an experienced NHS Consultant to offer immediate medical advice. The service will start with a Monday-Friday 08:30-16:30hrs
provision with an option to increase to 24 /7 for those working out of hours. This is inclusive in the PGD pricing offer.
ECG has been the market leader in providing vaccination training to pharmacists since 2004, providing robust knowledge and clinical skills to enable pharmacists to
develop their private and NHS commissioned vaccination services (such as flu and covid). By developing their close working relationship with all of the multiples,
many smaller chains, membership groups and independents over the years, ECG has continued to further consolidate their 'one stop shop' approach to supporting the
sector.
ECG wants to offer this sector choices in the level of guidance and support that the individual healthcare professionals feel they need to offer safe care to
patients.
The Pharmacists' Defence Association (PDA) is supporting pharmacists in England whose employment has been impacted by the creation of new NHS structures.
As a result of the 2022 Health and Care Act, Integrated Care Systems (ICSs) were established in England, and Clinical Commissioning Groups (CCGs) were closed on 1
July 2022. Each of the ICSs includes two key parts: an Integrated Care Board (ICB) and an Integrated Care Partnership (ICP).
The association said: "The previous structures in England, established by the Health and Social Care Act 2012, originally had over 200 clinical commissioning groups.
This number had reduced over recent years via mergers."
"However, this latest shift to just 42 commissioning entities means a significant change to significantly larger geographies and populations covered by each ICS.
Although each ICS and its activity can be subdivided into 'places', and within places into 'neighbourhoods', it is at the ICS level that the employer is formed."
"Whereas CCGs previously employed many local health professionals, including pharmacists, the new arrangements mean that ICBs are now that employer. The PDA is
supporting members who have contacted its Service Centre about the impact of these changes."
Trainee pharmacists across Great Britain are preparing to participate in Pharmacist Support's annual Trainee ACTNow Wellbeing Campaign, scheduled from
May 20th to 24th.
Organised by the charity, this initiative aims to provide essential support as trainees approach the culmination of their placements and gear up for the General
Pharmaceutical Council (GPhC) assessment.
Danielle Hunt, Chief Executive of Pharmacist Support, highlighted the campaign's focus on addressing the significant stress and pressure trainees may experience
during this critical period.
She stated: "We understand the anxiety and pressure they may feel, not only in preparing for the assessment but also in stepping into their roles as registered
pharmacists."
"If the Government does not support community pharmacies with the relevant funding, then we will see a massive number of closures," warns Dr. Leyla Hannbeck,
chief executive of the Independent Pharmacies Association (IPA).
The Fight4Pharmacies campaign, led by the IPA, is urging prime minister Rishi Sunak to address a critical £1.2 billion funding shortfall that threatens the survival
of independent pharmacies across the UK.
This urgent plea comes as 1,000 community pharmacies have closed since 2019 due to rising operational costs and insufficient reimbursements.
On May 21, supporters of the Fight4Pharmacies campaign, along with 50 MPs including prominent figures like Priti Patel and Gavin Williamson, delivered a petition
to Downing Street.
The petition, Prescription to Save Our Pharmacies outlines how independent community pharmacies can be supported to ensure smooth running of pharmacies.
The British Medical Association (BMA) has urged non-GP partners and contractors, including pharmacists, nurses, and physiotherapists, to support their
"Protect Your Patients, Protect Your GP Practice" campaign, which was launched to protest changes to the 2024/25 GP contract.
GP contractors and partners across England have strongly opposed the modifications to the GMS contract, leading to an ongoing dispute with the NHS.
The BMA highlights that general practice in England currently receives just 6 pence of every NHS pound and an average GMS 'global sum' of £107.57 per registered
patient annually.
Since 2018/19, CPI erosion to the GMS contract has resulted in a loss of £659 million, or 6.6%. This financial strain has contributed to the closure or merger
of over 1,300 practices over the past decade.
To address these issues, the BMA is urging all GP contractors and partner members to vote YES in the GPC England non-statutory ballot, which will be open
until July 29.
The International Pharmaceutical Federation (FIP) has announced its support for the Pharmacists' Defence Association (PDA)'s Safer Pharmacies Charter,
which aims to improve safety and care for patients, through better working conditions in UK pharmacy practice.
The Charter establishes basic standards to ensure safe practices across all pharmacy settings. It outlines seven commitments that, according to the PDA, "must be
standard practice whenever and wherever pharmacy work is carried out."
Dr Catherine Duggan, FIP CEO, said: "We are pleased to support the PDA's Safer Pharmacies Charter which defines basic standards to ensure safe practice wherever
pharmacists work.
"The overall objectives of the Charter align with FIP's development goals and overall mission."
FIP, the global body representing pharmacy and pharmaceutical sciences, plans to distribute the Charter among its members and share it with its Community Pharmacy
Section for information purposes.
GSK Consumer Healthcare has recently unveiled a three-year programme to support the pharmacy profession with additional practical resources, mental health provisions and proposed policy changes as part of its new report Standing with Pharmacists in the Age of Self-Care.
The new report summarises findings from a roundtable hosted by GSK Consumer Healthcare in collaboration with the International Pharmaceutical Federation (FIP) earlier this year, which convened the pharmacy community, policy experts, and industry leaders to discuss the critical role of pharmacy in the age of self-care following the Covid-19 pandemic.
"We've seen Covid-19 have a significant impact on consumers' understanding of self-care, leading to an increased focus on wellbeing and everyday healthcare. During this time, pharmacies played a vital role in providing care and advice to their patients - particularly with many other health facilities closed. Our research shows that more than half of Europeans are planning to consult their pharmacist more often than before the pandemic. Yet in general, pharmacists remain under-utilised, despite being the most widely distributed health resource in Europe," said Tess Player, global head of expert at GSK Consumer Healthcare.
Prime Minister Rishi Sunak was questioned whether he 'will take urgent action to prevent pharmacy closure'.
At Prime Minister's Questions (PMQs) in Parliament held on Wednesday (26 April) he replied, "we will continue to do everything we can to support community
pharmacies."
Labour MP for Knowsley and All-Party Pharmacy Group member, George Howarth said: "Given the chronic lack of capacity in the NHS, the Prime Minister will be aware
that community pharmacy can help deal with minor illnesses. But there is a problem on average 10 Pharmacy close every month in England."
Prime Minister was further asked "will he take urgent action to prevent further closing and commission a properly funded 'Pharmacy First' service for minor
illnesses?
Sunak replied: "I've been a wholehearted champion and believer in the role that community pharmacists can play. we want to make sure that they can do everything
to ease some of the pressures in primary care.
The Royal Pharmaceutical Society (RPS) has launched a new campaign to help parents and carers in pharmacy get the support they need in the workplace as part of
its inclusion and diversity work.
"A lack of flexibility in employment can mean work life balance is hard to keep, ramping up the pressure even more," said RPS.
The society wants to lift some of the burdens on parents and carers and challenge barriers to inclusion in the workplace.
It'll challenge negative attitudes to parents and carers through a brand new guide to the microaggressions you experience in the workplace. Drop in ABCD meeting at
7pm on 05 October to contribute your ideas.
It wants pharmacists to be able to choose flexible working whenever they need it. Join RPS's livestream across all its social media channels at 6.30pm on Weds 26
October to hear from two pharmacists about how to make it happen!
The menopause is a natural aging process, whereby a woman's oestrogen level drops thus disrupting periods until they eventually stop.
A woman is said to be in the menopause when her periods have stopped for 12 months. The age when this usually occurs is between 45-55 but symptoms can begin prior
to this. Symptoms vary and not all women experience them all.
They include hot flushes, vaginal dryness, joint and muscle pain, insomnia, reduced libido, urinary problems such as bladder weakness or Urinary Tract Infections
(UTIs), but this list is not exhaustive.
Up to a third of women declare that the menopause affects their quality of life. It is obvious that such physical changes can have an effect on ones well-being.
Women going through the menopause are at increased risk of developing depression, low self-esteem and problems with concentration (often called brain fog).
There are lots of misconceptions in the public and workplace around menopause as it is a little discussed topic. Did you know 45 per cent of women feel their
menopause symptoms have had a negative impact on their work and 47 per cent of women have said that they won't tell their employer if they need to take a day-off
from work because of menopausal symptoms?
So, with women making up nearly half of the UKs workforce, have you thought about what support your workplace offers for you? And if you are an employer, what could
you be doing to support your colleagues who need help during this time?
Ninety-six per cent of community pharmacists surveyed in the Royal Pharmaceutical Society (RPS) Workforce Wellbeing survey said they were at 'risk of burnout'.
A higher number of respondents working in community pharmacy (20%) reported not being offered breaks compared to all other sectors (8%) and were more likely to
experience verbal or physical abuse from patients and the public (69% vs an average 44%).
The annual Workforce Wellbeing survey also revealed that 88 per cent of pharmacists surveyed are at high risk of burnout due to winter pressure. Therefore, RPS is
calling for workforce planning for pharmacy to address skill mix and staffing levels so that workloads can be effectively managed.
Top factors causing poor mental health and wellbeing revealed by the survey include inadequate staffing (70%), lack of work/life balance (53%), lack of protected
learning time (48%) and lack of colleague/senior support (47%).
This is the fourth survey RPS has run in partnership with the charity Pharmacist Support on the state of mental health and wellbeing in pharmacy.
The findings demonstrate continued pressure on pharmacists and trainees across the workforce, especially in community pharmacy where 96% of those surveyed said they
were at risk of burnout.
The Royal Pharmaceutical Society (RPS) has backed a new framework from NHS England to reduce inappropriate prescribing of addiction-causing medicines.
It believes that the new framework is a positive step towards improving patient care by supporting medicine reviews and shared decision making to help people reduce
their use of medicines that are no longer providing much clinical benefit.
The society has also welcomed investment in innovative approaches to supporting patients and urged all pharmacists to refer people to such schemes.
Director for England at RPS, James Davies said: "Pharmacists are well-placed to help reduce inappropriate prescribing of high strength painkillers such as opioids
and other addictive medicines.
"Pharmacy teams can also often spot repeat purchases of over the counter medicines by patients so are well placed to intervene and give advice on the management of
chronic pain. Whilst opioids can play an important part in helping people with chronic pain there has long been a need for alternative approaches that are safer and
more effective for patients.
The Royal Pharmaceutical Society (RPS) England Chair Thorrun Govind has called for Government action to support pharmacy teams experiencing huge demand for
their services.
"Pharmacy teams are under immense pressure at the moment, in common with other NHS services, and working extremely hard with health service colleagues to provide
the right care for patients," said Govind.
"As winter pressures mount, pharmacies see increased numbers of patients seeking support with illness and also because they have heard other areas of the health
service are struggling to cope.
The society has also stated staffing pressures, alongside an increase in workload has created an extra burden which takes a toll on the wellbeing of pharmacy teams.
Govind added: "Issues such as medicine shortages can also take up many hours of time for pharmacy teams tracking down medicines when they could be directly helping
patients. In community pharmacies, rising costs and fairly static funding are adding to business pressures.
"However, pharmacies remain the most accessible part of the health service and provide expert advice to patients without the need for an appointment and are open
long hours and at weekends."
The Professional Pharmacists Association (PDA) has demanded efforts to secure greater support and recognition for community pharmacists from governmental
bodies.
In its written evidence provided to the Health and Social Care select committee's pharmacy inquiry, the PDA raised concerns about the well-being of pharmacists,
specifically for those who belong to minority ethnic groups and race and are subjected to bullying, harassment, and ill-treatment.
The association highlighted issues in the workplace that impact pharmacists' health and well-being, including chronic understaffing, sub-standard working
environments, an absence of protected training time, and experiences of racism, violence, and abuse.
Parallel to the PDA's advocacy, the Royal Pharmaceutical Society (RPS) is intensifying calls for prioritising workforce wellbeing within the pharmacy domain.
Stressing the pivotal role of workforce retention in addressing current challenges, RPS emphasises the need for robust support mechanisms and equitable access
to mental health services.